Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.33 |
| ▸ | THRB | P10828 | 2/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.33 |
| ▸ | BLM | P54132 | 2/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | MTOR | P42345 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2415798 | 1.00 | CYP19A1 (0.43) | CYP19A1CYP2D6LMNACHRM2CHRM4 | |
| SCHEMBL2419961 | 0.84 | CYP19A1 (0.50) | CYP19A1CYP2D6LMNACHRM2CHRM4 | |
| SCHEMBL7915891 | 0.84 | CYP19A1 (0.46) | CYP19A1CYP2D6LMNACHRM2CHRM4 | |
| SCHEMBL27798319 | 0.82 | CYP19A1 (0.42) | CYP19A1CYP2D6LMNACHRM2CHRM4 | |
| SCHEMBL26822901 | 0.82 | CYP19A1 (0.53) | CYP19A1EPHX1HTTGAANAAA | |
| SCHEMBL753308 | 0.82 | CYP19A1 (0.53) | CYP19A1EPHX1HTTGAANAAA | |
| SCHEMBL23054345 | 0.80 | CHRM2 (0.38) | CYP19A1CYP2D6CHRM2CHRM1CHRM3 | |
| SCHEMBL754296 | 0.80 | — | — | |
| SCHEMBL1628386 | 0.79 | EPHX1 (0.38) | CYP19A1LMNAEPHX1HTTPTGS1 | |
| SCHEMBL31490424 | 0.79 | EPHX1 (0.38) | CYP19A1LMNAEPHX1HTTPTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 100 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260096991-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | XAMPLA LTD (GB) | 2026-04-09 | — | — | US | disclosed |
| EP-4489592-B1 | BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION | XAMPLA LTD (GB) | 2025-12-24 | — | — | EP | disclosed |
| US-20250255827-A1 | BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION | XAMPLA LIMITED (GB) | 2025-08-14 | — | — | US | disclosed |
| EP-4593639-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | Xampla Limited (GB) | 2025-08-06 | — | — | EP | disclosed |
| US-20250186960-A1 | BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION | XAMPLA LIMITED (GB) | 2025-06-12 | — | — | US | disclosed |
| EP-3888782-B1 | COATED MICROCAPSULES | NOXELL CORP (US) | 2025-06-11 | — | — | EP | disclosed |
| US-20250177298-A1 | EMULSIONS AND A METHOD FOR THEIR PREPARATION | XAMPLA LIMITED (GB) | 2025-06-05 | — | — | US | disclosed |
| WO-2025109106-A1 | CORE-SHELL MICROCAPSULES | XAMPLA Ltd. (GB) | 2025-05-30 | — | — | WO | disclosed |
| EP-4489592-A1 | BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION | Xampla Limited (GB) | 2025-01-15 | — | — | EP | disclosed |
| EP-4489717-A1 | EMULSIONS AND A METHOD FOR THEIR PREPARATION | Xampla Limited (GB) | 2025-01-15 | — | — | EP | disclosed |
| US-20150351519-A1 | Articles Providing Long Lasting Fragrances | THE PROCTER & GAMBLE COMPANY | 2015-12-10 | — | — | US | disclosed |
| US-20150352575-A1 | Articles Providing Long Lasting Fragrances | THE PROCTER & GAMBLE COMPANY | 2015-12-10 | — | — | US | disclosed |
| US-20150353867-A1 | Articles Providing Long Lasting Fragrances | THE PROCTER & GAMBLE COMPANY | 2015-12-10 | — | — | US | disclosed |
| US-20150352578-A1 | Flushing Dispensers For Delivering A Consistent Consumer Experience | THE PROCTER & GAMBLE COMPANY | 2015-12-10 | — | — | US | disclosed |
| US-20150352576-A1 | Dispensers For Delivering A Consistent Consumer Experience | THE PROCTER & GAMBLE COMPANY | 2015-12-10 | — | — | US | disclosed |
| EP-2366014-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2015-11-04 | — | — | EP | disclosed |
| US-8754028-B2 | Perfume systems | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-17 | — | — | US | disclosed |
| EP-2366014-A2 | PERFUME SYSTEMS | The Procter & Gamble Company (US) | 2011-09-21 | — | — | EP | disclosed |
| US-20100152083-A1 | Perfume Systems | PROCTER & GAMBLE COMPANY, THE | 2010-06-17 | — | — | US | disclosed |
| WO-2009027957-A2 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2009-03-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260096991-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | PCTP, CLK4, MTCL3 | CYP19A1 4823/4885CYP2D6 4795/4885LMNA 1834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.